⚠ RNA is no longer actively traded. Data shown reflects verified historical relationships.
Supply Chain Intelligence

Atrium Therapeutics, Inc. Supply Chain

RNA supply chain intelligence for Atrium Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

RNA ·Last updated 2026-07-01 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

3Suppliers
0Customers
3Debt Items
20Related Chains

Atrium Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
LONZA-LTD LONZA-LTD 92% In August 2025, we entered into a Manufacturing Services Agreement, or the MSA, with Lonza LTD and Lonza Sales LTD, or together Lonza, pursuant to which Lonza has agreed to manufacture for us drug su…
LONZA-SALES-LTD LONZA-SALES-LTD 92% In August 2025, we entered into a Manufacturing Services Agreement, or the MSA, with Lonza LTD and Lonza Sales LTD, or together Lonza, pursuant to which Lonza has agreed to manufacture for us drug su…
AVIDITY AVIDITY 90% the Company granted to Avidity certain exclusive and non-exclusive licenses under the Company’s platform technology and other intellectual property, and Avidity granted to the Company certain exclusi…

Atrium Therapeutics, Inc. Customers

No clients on recordNo downstream customers found in our database for Atrium Therapeutics, Inc..

Atrium Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
RNA-DEBT-12240 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.
RNA-DEBT-12239 Warrants outstanding: 0 90% xbrl warrant detail from xbrl 2021-12-31.
RNA-DEBT Debt stack $2.7M 90% Market cache reports total debt of $2.7M.

Atrium Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Atrium Therapeutics, Inc..

Atrium Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
RNA-OWNER-AVORO-CAPITAL-ADVISORS-LLC Avoro Capital Advisors LLC 90% 13F overlay lists Avoro Capital Advisors LLC as top holder; 20 tracked holders.

Atrium Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
AZN AstraZeneca PLC 100.00 2
BCYC Bicycle Therapeutics plc 100.00 1 ['receiving']
DSGN Design Therapeutics, Inc. 100.00 1 ['receiving']
WHWK Whitehawk Therapeutics, Inc. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
DAWN Day One Biopharmaceuticals Inc 100.00 2
BLRX BioLineRx Ltd. 100.00 2
CRBP Corbus Pharmaceuticals Holdings, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
EMMA Emmaus Life Sciences, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
BEAM Beam Therapeutics Inc. 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
CPRX Catalyst Pharmaceuticals, Inc. 100.00 1 ['receiving']
CCEP Coca-Cola Europacific Partners PLC 100.00 2
CHRS Coherus Oncology, Inc. 100.00 2
View RNA supply chain intel →

Explore the full interactive supply chain map for Atrium Therapeutics, Inc..

Open RNA supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map